Related Experiment Videos
[Care recommendations for type 1 neurofibromatosis]
A Donadio1, L Garavelli, M E Lorenzetti
1Ambulatorio di Genetica Clinica, U.O di Pediatria, Arcispedale S. Maria Nuova, Reggio Emilia.
Acta Bio-Medica De L'Ateneo Parmense : Organo Della Societa Di Medicina E Scienze Naturali Di Parma
|June 27, 2001
Summary
Neurofibromatosis type 1 (NF1) is a genetic disorder affecting 1 in 3000 people. While understanding and management have improved, diagnosis relies on clinical criteria, with no definitive cure available.
Area of Science:
- Genetics
- Neurology
- Pediatrics
Context:
- Neurofibromatosis type 1 (NF1) is a prevalent genetic disorder affecting approximately 1 in 3000 individuals.
- While significant advancements have been made in understanding NF1's molecular basis, natural history, and management since the 1987 NIH Consensus Conference, diagnosis remains primarily clinical.
- A notable portion of patients experience severe complications, while others present with milder symptoms.
Purpose:
- To review the current understanding of Neurofibromatosis type 1 (NF1), including its molecular basis, natural history, and management.
- To highlight the diagnostic criteria and evolving care guidelines for NF1.
- To underscore the need for improved prognostic evaluations and therapeutic options.
Summary:
- NF1 is a progressive, multisystem genetic disorder with variable clinical manifestations.
- Diagnosis is based on established clinical criteria, with ongoing research into molecular underpinnings.
- Current management emphasizes surveillance for complications and anticipatory guidance, as definitive therapies are lacking.
Impact:
- Improved understanding of NF1 contributes to better patient care and family support.
- Evolving guidelines for NF1 management focus on proactive surveillance and early detection of complications.
- The lack of individual prognostic tools and definitive treatments highlights areas for future research and therapeutic development.